Title Statements
- Full title :Chronic Myeloid Leukemia / Rüdiger Hehlmann [edit.]
Edition Statements
- Publication Date:2021
- Edition:2nd ed. 2021
Publication Statements
- Publisher(s):Springer International Publishing
- Place of Publication:Cham
- Language:eng
- Publication Date:2021
The Physical Object
- Description:1 online resource
Edition Identifiers
- ISBN:9783030719135, 3030719138, 9783030719142, 3030719146, 9783030719159, 3030719154, 9783030719128, 303071912X
- DOI:10.1007/978-3-030-71913-5
- oclc:on1346738617
Table of Contents
Cytogenetics of Chronic Myeloid Leukemia (CML) -- The Biology and Pathogenesis of Chronic Myeloid Leukaemia -- Epidemiology of Chronic Myeloid Leukemia.-Imatinib and the first line CML Therapy -- CML Therapy: A Focus on Second and Third Generation Tyrosine Kinase Inhibitors -- Adverse events associated with ATP-competitive BCR-ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia -- Pharmacoeconomic considerations for tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia -- Standardization of molecular monitoring for chronic myeloid leukemia: 2021 update -- Prognostic Scores for Patients with Chronic Myeloid Leukemia under Particular Consideration of Disease-Specific Death -- A Review and an Update of European LeukemiaNet Recommendations for the Management of Chronic Myeloid Leukemia -- The Role of Hematopoietic Stem Cell Transplantation in CML -- CML end-phase and blast crisis: implications and management -- The Interferon-alpha Revival in CML -- Managing Pregnancy in Chronic Myeloid Leukemia -- Response-Related Predictors of Survival and of Treatment Free Remission in CML -- Discontinuation or cessation of tyrosine kinase inhibitor treatment in Chronic my…
Read More ↓Subjects
Writers
No reviews yet. Be the first to rate this work.
Related Works
more →
Haemostasis: methods and protocols
First aid for the basic sciences
Acute Leukemias
Rate & Review